Search research articles
Contact Us
Filters
Showing results (191-200 of 257) with videos related to
Page
of 26
Sort By:
Nature Cell Biology
|
August 17, 2023
KDM6A epigenetically regulates subtype plasticity in small cell lung cancer
Leslie Duplaquet, Yixiang Li, Matthew A Booker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 24, 2019
irRECIST for the Evaluation of Candidate Biomarkers of Response to Nivolumab in Metastatic Clear Cell Renal Cell Carcinoma: Analysis of a Phase II Prospective Clinical Trial
Jean-Christophe Pignon, Opeyemi Jegede, Sachet A Shukla, et al.
Nature Metabolism
|
February 6, 2025
Oncogenic TFE3 fusions drive OXPHOS and confer metabolic vulnerabilities in translocation renal cell carcinoma
Jiao Li, Kaimeng Huang, Meha Thakur, et al.
Cancer Discovery
|
March 15, 2014
Activating mTOR mutations in a patient with an extraordinary response on a phase I trial of everolimus and pazopanib
Nikhil Wagle, Brian C Grabiner, Eliezer M Van Allen, et al.
Nature Genetics
|
January 17, 2018
An aberrant SREBP-dependent lipogenic program promotes metastatic prostate cancer
Ming Chen, Jiangwen Zhang, Katia Sampieri, et al.
Nature Genetics
|
October 22, 2025
Author Correction: An aberrant SREBP-dependent lipogenic program promotes metastatic prostate cancer
Ming Chen, Jiangwen Zhang, Katia Sampieri, et al.
The Oncologist
|
June 27, 2023
Pathological Outcomes of Patients With Advanced Renal Cell Carcinoma Who Receive Nephrectomy Following Immunotherapy
Justine Panian, Ava Saidian, Kevin Hakimi, et al.
Cancer Cell
|
April 5, 2024
Impact of renal cell carcinoma molecular subtypes on immunotherapy and targeted therapy outcomes
Renée Maria Saliby, Chris Labaki, Tejas R Jammihal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 3, 2020
Efficacy and Safety of Nivolumab Plus Ipilimumab versus Sunitinib in First-line Treatment of Patients with Advanced Sarcomatoid Renal Cell Carcinoma
Nizar M Tannir, Sabina Signoretti, Toni K Choueiri, et al.
Developmental Cell
|
August 27, 2025
Loss of NOTCH2 creates a TRIM28-dependent vulnerability in small cell lung cancer
Deli Hong, Ying Lyu, Richa Nayak, et al.
Page
of 26
Search research articles
Search
Showing results (191-200 of 257) with videos related to
Sort By:
Page
of 26
Nature Cell Biology
|
August 17, 2023
KDM6A epigenetically regulates subtype plasticity in small cell lung cancer
Leslie Duplaquet, Yixiang Li, Matthew A Booker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 24, 2019
irRECIST for the Evaluation of Candidate Biomarkers of Response to Nivolumab in Metastatic Clear Cell Renal Cell Carcinoma: Analysis of a Phase II Prospective Clinical Trial
Jean-Christophe Pignon, Opeyemi Jegede, Sachet A Shukla, et al.
Nature Metabolism
|
February 6, 2025
Oncogenic TFE3 fusions drive OXPHOS and confer metabolic vulnerabilities in translocation renal cell carcinoma
Jiao Li, Kaimeng Huang, Meha Thakur, et al.
Cancer Discovery
|
March 15, 2014
Activating mTOR mutations in a patient with an extraordinary response on a phase I trial of everolimus and pazopanib
Nikhil Wagle, Brian C Grabiner, Eliezer M Van Allen, et al.
Nature Genetics
|
January 17, 2018
An aberrant SREBP-dependent lipogenic program promotes metastatic prostate cancer
Ming Chen, Jiangwen Zhang, Katia Sampieri, et al.
Nature Genetics
|
October 22, 2025
Author Correction: An aberrant SREBP-dependent lipogenic program promotes metastatic prostate cancer
Ming Chen, Jiangwen Zhang, Katia Sampieri, et al.
The Oncologist
|
June 27, 2023
Pathological Outcomes of Patients With Advanced Renal Cell Carcinoma Who Receive Nephrectomy Following Immunotherapy
Justine Panian, Ava Saidian, Kevin Hakimi, et al.
Cancer Cell
|
April 5, 2024
Impact of renal cell carcinoma molecular subtypes on immunotherapy and targeted therapy outcomes
Renée Maria Saliby, Chris Labaki, Tejas R Jammihal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 3, 2020
Efficacy and Safety of Nivolumab Plus Ipilimumab versus Sunitinib in First-line Treatment of Patients with Advanced Sarcomatoid Renal Cell Carcinoma
Nizar M Tannir, Sabina Signoretti, Toni K Choueiri, et al.
Developmental Cell
|
August 27, 2025
Loss of NOTCH2 creates a TRIM28-dependent vulnerability in small cell lung cancer
Deli Hong, Ying Lyu, Richa Nayak, et al.
Page
of 26